Inhibrx Biosciences Inc Financial Overview
Inhibrx Biosciences Inc's market cap is currently $1.22B. The company's EPS TTM is $-2.28; its P/E ratio is ―; Inhibrx Biosciences Inc is scheduled to report earnings on November 14, 2025, and the estimated EPS forecast is $-2.08. See an overview of income statement, balance sheet, and cash flow financials.
